Tradewinds Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.2K | Hold |
42
| – | – | ﹤0.01% | 312 |
|
|
2026
Q1 | $20.7K | Hold |
42
| – | – | ﹤0.01% | 315 |
|
|
2025
Q4 | $24.4K | Sell |
42
-5
| -11% | -$2.83K | 0.01% | 291 |
|
|
2025
Q3 | $22.8K | Buy |
47
+5
| +12% | +$2.33K | 0.01% | 288 |
|
|
2025
Q2 | $17.1K | Hold |
42
| – | – | ﹤0.01% | 296 |
|
|
2025
Q1 | $20.9K | Hold |
42
| – | – | 0.01% | 284 |
|
|
2024
Q4 | $21.9K | Hold |
42
| – | – | 0.01% | 284 |
|
|
2024
Q3 | $26K | Buy |
42
+39
| +1,300% | +$23.1K | 0.01% | 238 |
|
|
2024
Q2 | $1.66K | Buy |
+3
| New | +$1.72K | ﹤0.01% | 458 |
|
|
2022
Q2 | – | Sell |
-873
| Closed | -$516K | – | 765 |
|
|
2022
Q1 | $516K | Hold |
873
| – | – | 0.08% | 69 |
|
|
2021
Q4 | $583K | Hold |
873
| – | – | 0.09% | 70 |
|
|
2021
Q3 | $499K | Hold |
873
| – | – | 0.08% | 68 |
|
|
2021
Q2 | $441K | Hold |
873
| – | – | 0.08% | 70 |
|
|
2021
Q1 | $399K | Sell |
873
-74
| -8% | -$35.3K | 0.08% | 70 |
|
|
2020
Q4 | $441K | Hold |
947
| – | – | 0.1% | 66 |
|
|
2020
Q3 | $418K | Hold |
947
| – | – | 0.1% | 64 |
|
|
2020
Q2 | $343K | Sell |
947
-91
| -9% | -$30.5K | 0.09% | 69 |
|
|
2020
Q1 | $294K | Hold |
1,038
| – | – | 0.09% | 64 |
|
|
2019
Q4 | $337K | Buy |
1,038
+70
| +7% | +$21.2K | 0.11% | 70 |
|
|
2019
Q3 | $282K | Hold |
968
| – | – | 0.11% | 65 |
|
|
2019
Q2 | $284K | Hold |
968
| – | – | 0.12% | 66 |
|
|
2019
Q1 | $265K | Hold |
968
| – | – | 0.1% | 85 |
|
|
2018
Q4 | $217K | Hold |
968
| – | – | 0.11% | 90 |
|
|
2018
Q3 | $236K | Hold |
968
| – | – | 0.09% | 96 |
|
|
2018
Q2 | $201K | Hold |
968
| – | – | 0.08% | 106 |
|
|
2018
Q1 | $200K | Hold |
968
| – | – | 0.09% | 103 |
|
|
2017
Q4 | $184K | Hold |
968
| – | – | 0.09% | 110 |
|
|
2017
Q3 | $183K | Hold |
968
| – | – | 0.09% | 107 |
|
|
2017
Q2 | $169K | Buy |
968
+1
| +0.1% | +$168 | 0.09% | 107 |
|
|
2017
Q1 | $149K | Hold |
967
| – | – | 0.09% | 110 |
|
|
2016
Q4 | $136K | Hold |
967
| – | – | 0.09% | 115 |
|
|
2016
Q3 | $154K | Hold |
967
| – | – | 0.11% | 105 |
|
|
2016
Q2 | $143K | Hold |
967
| – | – | 0.1% | 112 |
|
|
2016
Q1 | $137K | Hold |
967
| – | – | 0.09% | 132 |
|
|
2015
Q4 | $137K | Buy |
967
+1
| +0.1% | +$133 | 0.1% | 128 |
|
|
2015
Q3 | $118K | Hold |
966
| – | – | 0.09% | 132 |
|
|
2015
Q2 | $125K | Hold |
966
| – | – | 0.09% | 136 |
|
|
2015
Q1 | $130K | Buy |
966
+40
| +4% | +$5.16K | 0.1% | 136 |
|
|
2014
Q4 | $116K | Hold |
926
| – | – | 0.08% | 148 |
|
|
2014
Q3 | $113K | Hold |
926
| – | – | 0.09% | 146 |
|
|
2014
Q2 | $109K | Sell |
926
-137
| -13% | -$16.1K | 0.08% | 154 |
|
|
2014
Q1 | $128K | Hold |
1,063
| – | – | 0.1% | 139 |
|
|
2013
Q4 | $118K | Buy |
+1,063
| New | +$106K | 0.1% | 144 |
|
Other funds holding TMO
Tradewinds Capital Management's TMO Position: Q2 2026 in Review
Tradewinds Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 42 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #312.
Tradewinds Capital Management first reported a position in TMO in Q4 2013 and has held it in 43 quarters since. The position peaked at $583K in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Tradewinds Capital Management held 42 shares of Thermo Fisher Scientific worth $21.2K as of Q2 2026.
- Tradewinds Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #312 holding.
- Tradewinds Capital Management first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 43 quarters since.
- Tradewinds Capital Management's Thermo Fisher Scientific position peaked at $583K in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.